Blood Cancers
FDA Approves Fedratinib for Patients With Myelofibrosis
BY BRIELLE BENYON
Understanding Chronic Lymphocytic Leukemia: Treatment, AEs, and More
BY KRISTIE L. KAHL
Adverse Events of CAR T-Cell Therapy
BY SATTVA S. NEELAPU, MD
Comorbidities Can Affect CML Treatment Decisions
BY NEIL SHAH, MD, PHD
FDA Takes Action Against Breast Implant-Associated Cancer
BY BRIELLE BENYON
Expert Discusses CAR T Cells, Other Advances in Mantle Cell Lymphoma
BY CAROLINE SEYMOUR
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.